Advertisement


Drugs Controller General Of India Dgci
West Bengal  /  Published 25.11.21

Needle-free ZyCov-D in Covid battle soon

After Covaxin, Covishield and Sputnik V, a fourth vaccine, DNA-based vaccine ZyCov-D is likely to be in use from next month in Bengal. The Union health ministry assured the state on Wednesday that it...
By Snehamoy Chakraborty in Bolpur(Birbhum)

India  /  Published 15.11.21

SII to export 5 crore jabs

  The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approve...
By Payal Banerjee in New Delhi

India  /  Published 12.10.21

Covaxin gets expert panel nod for 2 to 18 age group

An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain cond...
By Our Bureau, PTI in New Delhi

India  /  Published 05.10.21

Cadila: Nod for Covid jab trial

Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-D. The company has alread...
By Our Bureau, PTI in New Delhi

India  /  Published 21.08.21

Vaccine: Nod to jab for 12-plus kids

India has approved a DNA vaccine against Covid-19 developed by the Ahmedabad-based pharmaceutical company Zydus Cadila, the country’s second homegrown vaccine against the infection and the first...
By G.S. Mudur in New Delhi

Advertisement

India  /  Published 11.07.21

India's vaccine drive not as bad as it looks

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...
By Paran Balakrishnan in New Delhi

Business  /  Published 06.07.21

Shot in arm for Panacea

Shares of Panacea Biotec on Monday closed with gains of over 5 per cent after the company announced it has received a manufacturing licence for the Sputnik V vaccine. Panacea received the manufacturi...
By Our Special Correspondent in Mumbai

India  /  Published 01.07.21

Jabs: Zydus seeks emergency nod

Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Drug Controller General of India (DCGI) for its COVID-19 vaccine ZyCoV-D. The company said it has conducted...
By Our Bureau, PTI in New Delhi

India  /  Published 29.06.21

Moderna gets DCGI nod, Cipla to import vaccines

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sourc...
By Our Bureau, PTI in New Delhi

India  /  Published 11.06.21

Covid: Biophore seeks nod for emergency use of drug

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to se...
By Our Bureau, Agencies in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.